Medecine Nucleaire-Imagerie Fonctionnelle et Metabolique

Scope & Guideline

Transforming Knowledge in Functional and Metabolic Imaging.

Introduction

Delve into the academic richness of Medecine Nucleaire-Imagerie Fonctionnelle et Metabolique with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageFrench
ISSN0928-1258
PublisherELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
Support Open AccessNo
CountryFrance
TypeJournal
Convergefrom 1993 to 2024
AbbreviationMED NUCL / Med. Nucl.-Imag. Fonct. Metab.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE

Aims and Scopes

The journal 'Medecine Nucleaire-Imagerie Fonctionnelle et Metabolique' focuses on the integration of nuclear medicine and functional imaging techniques to enhance diagnosis, treatment planning, and therapeutic monitoring across various medical conditions, particularly cancers. This journal serves as a platform for disseminating research on innovative imaging modalities, radiopharmaceuticals, and their applications in clinical practice.
  1. Nuclear Medicine Applications:
    The journal covers a wide range of applications of nuclear medicine, including diagnostics, therapeutic interventions, and the development of new radiopharmaceuticals. It emphasizes the use of imaging techniques such as PET, SPECT, and CT in the management of various diseases.
  2. Functional Imaging Techniques:
    A significant focus is placed on advanced imaging modalities and their role in assessing metabolic and physiological processes in diseases, especially cancer. The integration of functional imaging with anatomical imaging enhances the accuracy of diagnosis and treatment evaluation.
  3. Theranostics and Personalized Medicine:
    The journal explores the concept of theranostics, which combines therapeutic and diagnostic approaches, particularly in oncology. This involves the use of targeted radionuclide therapies and personalized treatment plans based on imaging findings.
  4. Emerging Technologies in Imaging:
    Research on novel imaging techniques and technologies, such as digital PET and radiomics, is a core area of interest. The journal discusses advancements that improve imaging quality, quantification, and the ability to predict treatment responses.
  5. Clinical Case Studies and Guidelines:
    The publication includes detailed case studies and clinical practice guidelines that contribute to the understanding of best practices in nuclear medicine and imaging, aiding clinicians in decision-making.
Recent publications in 'Medecine Nucleaire-Imagerie Fonctionnelle et Metabolique' indicate a shift towards emerging themes that reflect current challenges and advancements in nuclear medicine and imaging. These trends suggest a growing interest in integrating new technologies and personalized approaches in clinical practice.
  1. Oncological Imaging Innovations:
    Recent papers show a marked increase in research related to oncological imaging, particularly the use of PET/CT and PET/MR in cancer diagnosis, staging, and treatment response evaluation. This trend highlights the importance of accurate imaging in managing cancer patients.
  2. Theranostic Approaches in Cancer Treatment:
    Emerging themes include the use of theranostic approaches, particularly with PSMA-targeted therapies for prostate cancer. This reflects a broader trend towards combining diagnostics and therapeutics to provide personalized cancer care.
  3. Advanced Imaging Techniques and Radiomics:
    There is a growing interest in advanced imaging techniques and radiomics, which analyze imaging data to predict treatment responses and outcomes. This trend indicates a shift towards quantitative imaging and machine learning applications in nuclear medicine.
  4. Imaging Biomarkers and Prognostic Indicators:
    Recent studies are increasingly focusing on the correlation between imaging biomarkers and clinical outcomes, emphasizing the role of imaging in risk stratification and treatment planning.
  5. Integration of AI and Machine Learning in Imaging:
    The inclusion of artificial intelligence and machine learning in imaging analysis is gaining traction, suggesting a future direction where computational methods enhance diagnostic accuracy and efficiency in nuclear medicine.

Declining or Waning

As the field of nuclear medicine evolves, certain themes have shown a decline in prominence within the journal's publications. These waning scopes may reflect shifts in research focus or advancements in technology that render previous methodologies less relevant.
  1. Traditional Imaging Techniques:
    There is a noticeable decline in the focus on traditional imaging techniques that do not incorporate the advancements of hybrid imaging modalities such as PET/CT or PET/MR. Research in this area has been overshadowed by the increasing relevance of integrated imaging approaches.
  2. General Nuclear Medicine Procedures:
    Publications that discuss general nuclear medicine procedures without specific applications or innovative methodologies have decreased. This suggests a shift towards more specialized and targeted research.
  3. Basic Research on Radiopharmaceuticals:
    While the development of new radiopharmaceuticals remains important, there has been a reduction in basic research papers focused solely on radiopharmaceutical chemistry, as the journal favors studies that demonstrate clinical application and efficacy.
  4. Non-Oncological Applications:
    The focus on non-oncological applications of nuclear medicine, such as cardiology or endocrinology, appears to be waning. The journal is increasingly centered on oncology, particularly in the context of personalized treatment and imaging.

Similar Journals

EUROPEAN RADIOLOGY

Exploring Innovations in Diagnostic Imaging
Publisher: SPRINGERISSN: 0938-7994Frequency: 12 issues/year

EUROPEAN RADIOLOGY, published by SPRINGER, stands as a prestigious international journal in the field of radiology, nuclear medicine, and imaging, with an impressive impact factor that underscores its significance among peers. With an ISSN of 0938-7994 and an E-ISSN of 1432-1084, this journal provides a platform for cutting-edge research and advancements in medical imaging from 1991 to 2024. Recognized as a Q1 journal in both general Medicine and the specialized Radiology category by 2023, EUROPEAN RADIOLOGY ranks an impressive #17 out of 333 in its field according to Scopus, placing it in the 95th percentile. While it does not currently offer Open Access options, the journal remains essential reading for researchers, professionals, and students striving to stay at the forefront of developments in diagnostic imaging and related technologies. By contributing to a comprehensive understanding of radiological practices, EUROPEAN RADIOLOGY plays a crucial role in shaping the future of medical diagnosis and patient care.

Imaging

Advancing the Frontiers of Medical Imaging
Publisher: AKADEMIAI KIADO ZRTISSN: Frequency: 2 issues/year

Imaging, published by AKADEMIAI KIADO ZRT, is an esteemed open-access journal dedicated to the field of medical imaging, established in 2020. With an E-ISSN of 2732-0960 and based in Budapest, Hungary, this journal provides a vital platform for the dissemination of cutting-edge research and advancements in imaging techniques, especially in the realms of radiology, nuclear medicine, and ultrasound technology. While currently positioned in the Q4 category across multiple medical specialties, the journal continues to strive for improvements in visibility and impact, contributing to the evolving discourse in medical imaging. The journal aims to facilitate an inclusive and collaborative environment for researchers, professionals, and students, inviting them to share their findings and insights to enhance the field's development. With open-access availability since its inception, Imaging ensures free and easy access to its content, fostering a greater understanding and appreciation of innovative imaging practices worldwide.

CANCER IMAGING

Transforming Cancer Research Through Cutting-Edge Imaging
Publisher: BMCISSN: 1740-5025Frequency: 1 issue/year

CANCER IMAGING, published by BMC, stands as a leading open-access journal in the realms of oncology and medical imaging, significantly contributing to the advancement of cancer research since its inception in 2000. With an impressive impact across multiple domains—most notably ranking Q1 in prestigious categories such as Medicine (miscellaneous), Oncology, and Radiology—this journal ensures high visibility and influence within the academic community. As of 2023, it is recognized in various Scopus rankings, securing top positions in the fields of Radiology, Nuclear Medicine, and Imaging, alongside Radiological and Ultrasound Technology. The journal's commitment to open-access publication, adopted in 2014, enhances accessibility for researchers, healthcare professionals, and students alike, fostering an inclusive environment for sharing critical advancements and innovative methodologies in cancer imaging. Set in the vibrant landscape of the United Kingdom, CANCER IMAGING continues to play a vital role in elucidating the complexities of cancer diagnostics and treatment, establishing itself as an essential resource for those pursuing excellence in cancer care and research.

ANNALS OF NUCLEAR MEDICINE

Exploring Breakthroughs in Radiopharmaceutical Research
Publisher: SPRINGERISSN: 0914-7187Frequency: 10 issues/year

ANNALS OF NUCLEAR MEDICINE is a prominent academic journal dedicated to the field of nuclear medicine, published by Springer. With a rich publication history dating back to 1987 and continuing through 2024, this journal serves as a vital resource for researchers and practitioners interested in the latest developments in nuclear imaging, radiopharmaceuticals, and therapeutic applications. Ranked in the second quartile (Q2) for both Medicine (miscellaneous) and Radiology, Nuclear Medicine, and Imaging categories in 2023, it maintains a strong position in the academic community, with an impressive Scopus rank of #104 out of 333 in its field, placing it in the 68th percentile. The journal is not open access but offers a range of access options through institutional or individual subscriptions, ensuring that critical research findings reach a wide audience. By fostering high-quality, peer-reviewed articles, ANNALS OF NUCLEAR MEDICINE plays a crucial role in advancing the understanding and practical application of nuclear medicine techniques, making it an essential journal for professionals and students aiming to stay at the forefront of this evolving discipline.

NUCLEAR MEDICINE AND BIOLOGY

Exploring innovative applications of nuclear techniques.
Publisher: ELSEVIER SCIENCE INCISSN: 0969-8051Frequency: 8 issues/year

NUCLEAR MEDICINE AND BIOLOGY, published by Elsevier Science Inc, is a premier journal dedicated to advancing the fields of nuclear medicine and molecular biology. Since its inception in 1986, this journal has served as a vital platform for the dissemination of high-quality research, with a clear focus on the innovative applications of nuclear techniques in biological settings. It is categorized in the Q3 tier for both Cancer Research and Molecular Medicine, and Q2 for Radiology, Nuclear Medicine and Imaging, highlighting its significant standing within these disciplines. The journal's Scopus rankings reflect its strong impact, placing it in the top quartile of its categories, particularly in Radiology, Nuclear Medicine, and Imaging. Researchers, professionals, and students alike will find this an invaluable resource for contemporary research findings and methodologies in nuclear medicine and its biological applications. Access to the journal is provided through subscription, ensuring that quality content remains available to its wide-ranging audience.

SEMINARS IN NUCLEAR MEDICINE

Empowering healthcare with cutting-edge insights.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0001-2998Frequency: 6 issues/year

Welcome to Seminars in Nuclear Medicine, a prestigious journal published by W B Saunders Co-Elsevier Inc that has been at the forefront of the field since its inception in 1971. This journal serves as a dedicated forum for researchers, healthcare professionals, and students specializing in the rapidly evolving areas of radiology and nuclear medicine. With an impressive ranking of #29 out of 333 in the Scopus category, drawing an esteemed 91st percentile, it holds a distinguished Q1 category status, highlighting its critical role in disseminating high-quality research and clinical practices. Although it does not operate as an Open Access publication, Seminars in Nuclear Medicine remains a vital resource, featuring comprehensive reviews and insightful articles that inform the medical community about the latest advancements and applications within nuclear imaging. This journal not only enhances knowledge but also encourages collaboration among professionals dedicated to improving patient outcomes through innovative nuclear medicine techniques.

NUCLEAR MEDICINE REVIEW

Pioneering Insights in Nuclear Imaging
Publisher: VIA MEDICAISSN: 1506-9680Frequency: 2 issues/year

NUCLEAR MEDICINE REVIEW is a distinguished journal in the field of radiology, nuclear medicine, and imaging, published by VIA MEDICA in Poland. Since its transition to an open access format in 1999, this journal has been dedicated to promoting the dissemination of knowledge and research findings across a global audience. With a focus on innovative approaches and advancements in nuclear medicine, it aims to serve as a key resource for researchers, professionals, and students who are working to further the understanding of nuclear imaging and its applications. In 2023, the journal was classified in the Q3 category within Radiology, Nuclear Medicine and Imaging, and Q4 in the broader category of Medicine (miscellaneous), highlighting its growing reputation in the academic community. As of the latest assessments, the journal has been ranked #235 out of 333 in its field according to Scopus metrics, reflecting its commitment to excellence and the relevance of its published works. The NUCLEAR MEDICINE REVIEW is a pivotal platform for those engaged in cutting-edge research, providing insights that drive the evolution of medical imaging and therapeutic techniques.

NUCLEAR MEDICINE COMMUNICATIONS

Transforming Patient Care Through Nuclear Insights
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0143-3636Frequency: 12 issues/year

NUCLEAR MEDICINE COMMUNICATIONS is a prestigious academic journal published by Lippincott Williams & Wilkins, focusing on the multifaceted field of nuclear medicine and its applications in diagnostics and therapy. With a solid history spanning from 1980 to 2024, this journal provides a platform for peer-reviewed research articles, clinical studies, and innovative techniques that enrich the knowledge base within the fields of {{medicinal applications, patient care, and imaging technology}}. Currently classified in the Q3 quartile for both Medicine (Miscellaneous) and Radiology, Nuclear Medicine, and Imaging, the journal reflects its commitment to advancing healthcare practices. Although it does not offer open access options, its accessibility through reputable institutions promotes scholarly exchange among researchers, professionals, and students alike. The critical insights provided in NUCLEAR MEDICINE COMMUNICATIONS are essential for those dedicated to enhancing patient outcomes through cutting-edge nuclear medical technologies.

American Journal of Nuclear Medicine and Molecular Imaging

Pioneering Research in Molecular Imaging and Radiopharmaceuticals
Publisher: E-CENTURY PUBLISHING CORPISSN: 2160-8407Frequency: 6 issues/year

The American Journal of Nuclear Medicine and Molecular Imaging (ISSN: 2160-8407), published by E-CENTURY PUBLISHING CORP, is a distinguished platform for the dissemination of cutting-edge research in the fields of nuclear medicine and molecular imaging. With a commitment to advancing scientific inquiry and clinical applications, this journal serves as a vital resource for researchers, clinicians, and students dedicated to exploring innovative imaging modalities, radiopharmaceuticals, and their applications in diagnosing and treating various medical conditions. Although currently not available as an open-access journal, this publication plays a crucial role in fostering academic dialogue and collaboration within the medical community. Its diverse range of topics and expert contributions underscore its impact in bridging the gap between research findings and clinical practice, making it an essential read for anyone interested in the rapidly evolving landscape of nuclear medicine and imaging technologies.

Current Medical Imaging

Elevating Standards in Radiology and Internal Medicine
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1573-4056Frequency: 6 issues/year

Current Medical Imaging is a reputable journal published by Bentham Science Publishers, specializing in the dynamic field of medical imaging, with a strong emphasis on both clinical applications and technological advancements. Established in 2007, the journal has made significant contributions to the fields of Internal Medicine and Radiology, consistently ranking in the Q3 quartile for these categories as of 2023. The journal's ISSN 1573-4056 and E-ISSN 1875-6603 ensure wide accessibility for scholarly communication, although it operates under a traditional access model. With its continuous publication from 2011 to 2024, Current Medical Imaging aims to bridge the gap between advanced imaging techniques and their practical application in patient care, making it indispensable for researchers, healthcare professionals, and students eager to stay at the forefront of innovations in imaging technology and clinical practice.